Financials
- Market Capitalization 291.02 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.7
Rapporto prezzo/fatturato
0.05
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3261 | PRLD Prelude Therapeutics Incorporated - Common Stock | 3.74 USD | -3.86% | -1.58% | -18.70% | +194.49% | 298.47 M USD | ||
| 3264 | QSI Quantum-Si Incorporated - Class A Common Stock | 1.36 USD | -11.11% | +5.43% | +86.30% | -32.34% | 297.68 M USD | ||
| 3293 | EYPT EyePoint, Inc. - Common Stock | 3.32 USD | -2.35% | +4.40% | -22.61% | -72.33% | 286.22 M USD | ||
| 3295 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.75 USD | -0.53% | +0.81% | -1.83% | -56.40% | 286.11 M USD |